2m 2m 2m 2m 2m 2m 2m
TREACE MED CNCPT (TMCI)
NASDAQ
$4.50+$0.005 (+0.11%)
Price as of Jun 23, 2026 7:05 PM EDT- $260.1MMarket Cap
- -24.16%1-Year Change
- Medical DevicesIndustry
TREACE MED CNCPT (TMCI)
$4.50+$0.005 (+0.11%)
TMCI | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $4.49 | ||
Change | +$0.48 (+11.97%) | ||
Open | $3.98 | ||
High | $4.55 | ||
Low | $3.97 | ||
Previous Close | $4.01 | ||
Volume | 1,269,390 | ||
30-Day Average Volume | 778,807 | ||
1-Week Change | 8.98% | ||
1-Month Change | 61.51% | ||
1-Year Change | -24.16% | ||
3-Year Change | -82.43% | ||
5-Year Change | -86.28% | ||
Fundamentals | |||
Shares Outstanding | 64.9M | ||
Total Assets | $184.1M | ||
Market Cap | $260.1M | ||
Enterprise Value | $308.2M | ||
Period: QTR TTM FY | |||
Revenue | $47.2M | ||
Net Income | -$18.0M | ||
Free Cash Flow | $4.2M | ||
EBIT | -$16.4M | ||
EBITDA | -$15.5M | ||
Net Working Capital | $89.0M | ||
EPS | -$0.28 | ||
Enterprise Value/EBITDA | -20 | ||
Enterprise Value/Revenue | 7 | ||
P/B | 3 | ||
P/E | -14 | ||
PEG | 0 | ||
Price/Free Cash Flow | 62 | ||
Price/Operating Cash Flow | 36 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue